RKDA Stock Overview
Produces and markets plant-based food and beverage products in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
+ 1 more risk
My Notes
Capture your thoughts, links and company narrative
Arcadia Biosciences, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$6.35 |
| 52 Week High | US$10.31 |
| 52 Week Low | US$1.85 |
| Beta | 1.17 |
| 1 Month Change | 139.17% |
| 3 Month Change | 116.72% |
| 1 Year Change | 115.25% |
| 3 Year Change | -85.02% |
| 5 Year Change | -97.41% |
| Change since IPO | -99.89% |
Recent News & Updates
Recent updates
We're Hopeful That Arcadia Biosciences (NASDAQ:RKDA) Will Use Its Cash Wisely
Mar 01
Arcadia Biosciences to raise $5M in securities offering
Aug 15Arcadia Biosciences: Market Still Unconvinced Of Its Health Offerings
Nov 29We Think Shareholders Should Be Aware Of Some Factors Beyond Arcadia Biosciences' (NASDAQ:RKDA) Profit
Nov 22The Future Looks Bright For Arcadia Biosciences
Dec 01Arcadia Biosciences EPS misses by $0.06
Nov 12Shareholder Returns
| RKDA | US Food | US Market | |
|---|---|---|---|
| 7D | 0.8% | -5.0% | -3.5% |
| 1Y | 115.3% | -5.2% | 22.1% |
Return vs Industry: RKDA exceeded the US Food industry which returned -5.2% over the past year.
Return vs Market: RKDA exceeded the US Market which returned 22.1% over the past year.
Price Volatility
| RKDA volatility | |
|---|---|
| RKDA Average Weekly Movement | 32.2% |
| Food Industry Average Movement | 4.8% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 17.0% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: RKDA's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: RKDA's weekly volatility has increased from 19% to 32% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2002 | 21 | Thomas Schaefer | www.arcadiabio.com |
Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.
Arcadia Biosciences, Inc. Fundamentals Summary
| RKDA fundamental statistics | |
|---|---|
| Market cap | US$8.49m |
| Earnings (TTM) | -US$8.57m |
| Revenue (TTM) | US$5.48m |
1.6x
P/S Ratio-1.0x
P/E RatioIs RKDA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RKDA income statement (TTM) | |
|---|---|
| Revenue | US$5.48m |
| Cost of Revenue | US$4.37m |
| Gross Profit | US$1.11m |
| Other Expenses | US$9.68m |
| Earnings | -US$8.57m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -6.28 |
| Gross Margin | 20.32% |
| Net Profit Margin | -156.29% |
| Debt/Equity Ratio | 0% |
How did RKDA perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/20 00:07 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Arcadia Biosciences, Inc. is covered by 4 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Raghuram Selvaraju | H.C. Wainwright & Co. |
| Benjamin Klieve | Lake Street Capital Markets, LLC |
| Jon Ritzenthaler | Piper Sandler Companies |